Atlas Trials

The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT00758160 · COMPLETED

Trial details

NCT number
NCT00758160
Sponsor
Johnson & Johnson Taiwan Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Disorder With Hyperactivity
Start date
2008-03-01
Primary completion
2008-06-01
Enrollment
296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.